FDA NDC Directory · JSON-LD · Markdown

Viri Sode

NDC 83027-0304 · HUMAN OTC DRUG · SPRAY

Generic nameCytomegalovirus Nosode, Herpes Simplex I and II Nosode, Influenzinum, Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein-Barr Virus Nosode, Herpes Zoster Nosode
Labeler / ManufacturerNutritional Specialties, Inc.
Marketing categoryUNAPPROVED HOMEOPATHIC
Dosage form / routeSPRAY · ORAL
Active ingredientsHUMAN HERPESVIRUS 5 (16 [hp_X]/mL)
HUMAN HERPESVIRUS 1 (30 [hp_X]/mL)
HUMAN HERPESVIRUS 2 (30 [hp_X]/mL)
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 [hp_C]/mL)
INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (15 [hp_C]/mL)
INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE (15 [hp_C]/mL)
INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE (15 [hp_C]/mL)
RUBELLA VIRUS (16 [hp_X]/mL)
HEPATITIS A VIRUS (30 [hp_X]/mL)
HEPATITIS B VIRUS (30 [hp_X]/mL)
HEPATITIS C VIRUS (30 [hp_X]/mL)
HUMAN HERPESVIRUS 4 (15 [hp_C]/mL)
HUMAN HERPESVIRUS 3 (15 [hp_C]/mL)
Marketing started20260518
Package count1

External sources

Source: openFDA. Public-domain (CC0).